[Administrative and juridicial problems in psychopharmacology (author's transl)].
The problem of a juridical and administrative regulation for therapeutic drugs is analyzed. There are 3 concurring factors of public interest: 1. protection of the patient against dangerous side-effects, 2. promotion of new effective therapies. 3. position and responsibility of the physician. Risks and problems of control are discussed in the light of development of a new preparation. A scheme of functions in the clinical trial under auspices of medico-ethical postulations is mentioned. Restrictive facts on behalf of a quick development of drug therapy are discussed. The necessity of intensifying biological basic research is emphasized.
D000818:Animals; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004358:Drug Therapy; D004335:Drug and Narcotic Control; D005060:Europe; D006801:Humans; D007603:Jurisprudence; D007880:Legislation, Drug; D010347:Patient Care Planning; D011600:Psychopharmacology; D012106:Research; D014481:United States
Administrative und juristische Probleme der Psychopharmakologie